ES2169223T3 - Substancia anticancerosa que inhibe la metastasis cancerosa. - Google Patents

Substancia anticancerosa que inhibe la metastasis cancerosa.

Info

Publication number
ES2169223T3
ES2169223T3 ES96901963T ES96901963T ES2169223T3 ES 2169223 T3 ES2169223 T3 ES 2169223T3 ES 96901963 T ES96901963 T ES 96901963T ES 96901963 T ES96901963 T ES 96901963T ES 2169223 T3 ES2169223 T3 ES 2169223T3
Authority
ES
Spain
Prior art keywords
metastasis
cancerose
target substance
substance inhibiting
cancer cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901963T
Other languages
English (en)
Inventor
Takaaki Hasegawa
Kenichi Miyamoto
Mitsuo Kawase
Yasuko Yoshida
Tadahiko Inukai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NGK Insulators Ltd
Biseiken Co Ltd
Original Assignee
NGK Insulators Ltd
Biseiken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NGK Insulators Ltd, Biseiken Co Ltd filed Critical NGK Insulators Ltd
Application granted granted Critical
Publication of ES2169223T3 publication Critical patent/ES2169223T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C07H7/027—Keto-aldonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION ESTA DIRIGIDA A LA DESCRIPCION DE UN AGENTE ANTICANCEROSO QUE PUEDE INHIBIR LA METASTASIS DE CELULAS CANCEROSAS CUANDO SE UTILIZA POR SI SOLO. ADEMAS, LA PRESENTE INVENCION TAMBIEN ESTA DIRIGIDA A LA DESCRIPCION DE UN AGENTE ANTICANCEROSO QUE PUEDE INHIBIR LA METASTASIS DE CELULAS CANCEROSAS PROVOCANDO UN PEQUEÑO EFECTO SECUNDARIO Y MUY POCA TOXICIDAD INCLUSO DURANTE UN LARGO TIEMPO DE ADMINISTRACION. EL AGENTE ANTICANCEROSO QUE INHIBE LA METASTASIS CANCEROSA SEGUN LA PRESENTE INVENCION SE CARACTERIZA PORQUE CONTIENE ACIDO SIALICO, SU SAL, UN POLIMERO DEL ACIDO SIALICO O UNA SAL DEL POLIMERO COMO UN INGREDIENTE EFICAZ.
ES96901963T 1996-02-08 1996-02-08 Substancia anticancerosa que inhibe la metastasis cancerosa. Expired - Lifetime ES2169223T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1996/000268 WO1997028807A1 (fr) 1996-02-08 1996-02-08 Substance anticancereuse inhibant le processus metastatique cancereux

Publications (1)

Publication Number Publication Date
ES2169223T3 true ES2169223T3 (es) 2002-07-01

Family

ID=14152897

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901963T Expired - Lifetime ES2169223T3 (es) 1996-02-08 1996-02-08 Substancia anticancerosa que inhibe la metastasis cancerosa.

Country Status (7)

Country Link
US (1) US6083931A (es)
EP (1) EP0821963B1 (es)
KR (1) KR19980703698A (es)
CA (1) CA2217710C (es)
DE (1) DE69617415T2 (es)
ES (1) ES2169223T3 (es)
WO (1) WO1997028807A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2800984B1 (fr) 1999-11-17 2001-12-14 Jacques Seguin Dispositif de remplacement d'une valve cardiaque par voie percutanee
US20070043435A1 (en) 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
CN101641061B (zh) 2006-12-06 2013-12-18 美顿力科尔瓦有限责任公司 用于环锚固的自膨胀瓣膜的经心尖递送的系统和方法
US8475523B2 (en) 2010-02-17 2013-07-02 Medtronic, Inc. Distal tip assembly for a heart valve delivery catheter
US8518106B2 (en) 2010-02-17 2013-08-27 Medtronic, Inc. Catheter assembly with valve crimping accessories
US8926693B2 (en) 2010-02-17 2015-01-06 Medtronic, Inc. Heart valve delivery catheter with safety button
US9414914B2 (en) 2010-02-24 2016-08-16 Medtronic Ventor Technologies Ltd. Catheter assembly with valve crimping accessories
US9545306B2 (en) 2010-04-21 2017-01-17 Medtronic, Inc. Prosthetic valve with sealing members and methods of use thereof
US9387077B2 (en) 2010-05-27 2016-07-12 Medtronic Vascular Galway Catheter assembly with prosthesis crimping and prosthesis retaining accessories
FR3034642B1 (fr) 2015-04-07 2021-01-15 Benjamin Faurie Introducteur pour ensemble de remplacement d'une valve cardiaque ou pour ensemble d'angioplastie coronaire
ES2892273T3 (es) 2016-10-07 2022-02-03 Electroducer Conjunto de sustitución de una válvula cardíaca o de un conjunto de angioplastia coronaria
WO2019185880A1 (fr) 2018-03-29 2019-10-03 Electroducer Ensemble de pose d'un implant cardiaque, aortique ou arteriel avec assistance de stimulation par catheter pour voie arterielle ou veineuse peripherique
FR3079404B1 (fr) 2018-03-29 2020-03-06 Electroducer Ensemble de remplacement d’une valve cardiaque avec assistance de stimulation par voie arterielle ou veineuse peripherique
JP2021042189A (ja) * 2019-09-06 2021-03-18 均 石井 抗がん剤。

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60190791A (ja) * 1984-03-09 1985-09-28 Kanto Ishi Pharma Co Ltd シアル酸誘導体およびその製造法
JPS6183125A (ja) * 1984-09-28 1986-04-26 Kanto Ishi Pharma Co Ltd 癌転移阻害剤
JPS62132895A (ja) * 1985-12-05 1987-06-16 Mect Corp 癌転移阻害剤の製造方法
JPH0684307B2 (ja) * 1986-03-26 1994-10-26 メクト株式会社 新規癌転移阻害剤
JPH03245784A (ja) * 1990-02-23 1991-11-01 Toshiba Corp モータ制御装置
US5438125A (en) * 1991-03-06 1995-08-01 Nippon Zoki Pharmaceutical Co., Ltd. Sialic acid derivatives
ATE338762T1 (de) * 1991-04-19 2006-09-15 Univ Leland Stanford Junior Zusammensetzungen und methoden für die verknüpfung von endothelzellen
EP0521692A3 (en) * 1991-07-02 1993-02-03 The Biomembrane Institute Inhibition of tumor cell metastasis potential and invasiveness by chemically-defined oligosaccharides, their derivatives, mimetics and antibodies directed to them
JPH06245784A (ja) * 1993-02-19 1994-09-06 Taiyo Kagaku Co Ltd シアル酸及びシアル酸誘導体含有組成物の製造方法
GB9422584D0 (en) * 1994-02-15 1995-01-04 Medical Res Council Immunomodulation using oligosaccharides

Also Published As

Publication number Publication date
KR19980703698A (ko) 1998-12-05
CA2217710C (en) 2002-05-28
DE69617415D1 (de) 2002-01-10
WO1997028807A1 (fr) 1997-08-14
EP0821963B1 (en) 2001-11-28
DE69617415T2 (de) 2002-08-01
EP0821963A1 (en) 1998-02-04
US6083931A (en) 2000-07-04
EP0821963A4 (en) 1999-07-14
CA2217710A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
ES2169223T3 (es) Substancia anticancerosa que inhibe la metastasis cancerosa.
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR024874A1 (es) Composiciones bactericidas
ES2152701T3 (es) Composiciones acuosas desinfectantes y de limpieza.
BR9906903A (pt) Composição com liberação sustentada, processos para produzir a mesma, para suprimir a brusca liberação inicial da susbtância bioativa de uma composição com liberação sustentada e para aumentar a eficiência da inclusão da substância bioativa em uma composição com liberação sustentada, produto farmacêutico, agente para prevenir ou tratar câncer prostático, hipertrofia prostática, endometriose, histeromioma, metrofibroma, puberdade precoce, dismenorréia, ou câncer do seio, ou um contraceptivo, e, composto
ES2194968T3 (es) Composiciones acuosas,alcalinas, que contienen blanqueadores de peroxido de hidrogeno.
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
ES2109779T3 (es) Emulsion que contiene acido ascorbico estabilizado.
ES2195189T3 (es) Benzonaftiridinas como agentes terapeuticos bronquiales.
ES2125535T5 (es) Mezclas, que contienen isocianatos emulsionables en agua.
ES2192668T3 (es) Compuestos biciclicos-aromaticos.
ES2152016T3 (es) Solucion oftalmica de pranoprofeno conteniendo amina organica.
ES2133412T3 (es) 2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma.
ES2190082T3 (es) Concentrados estables de vitamina c.
CO4700420A1 (es) Formulacion transdermica
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
LT2000087A (lt) Dezinfekavimo kompozicija
ES2180729T3 (es) Tratamiento terapeutico combinado de las patologias hiperproliferantes.
GT200200015A (es) Formulacion agroquimica
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
CO4750591A1 (es) Procedimiento de lucha contra los insectos
MX9304456A (es) Composiciones pesticidas estables en almacenamiento que comprenden azadiractina y epoxido.
BR0009194A (pt) Composição do resorcinol
AR020695A1 (es) Metodos para controlar macroinvertebrados en sistemas acuosos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 821963

Country of ref document: ES